A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas
Lassen, Ulrik, Jensen, Lars Henrik, Sorensen, Morten, Rohrberg, Kristoffer S., Ujmajuridze, Zaza, Jakobsen, AndersVolume:
50
Language:
english
Journal:
Acta Oncologica
DOI:
10.3109/0284186x.2010.500300
Date:
April, 2011
File:
PDF, 119 KB
english, 2011